David Kim

David founded CyanoCapture in 2021, a biotech company based in Oxford using a patented genetically engineered bacteria to make industrial scale CO2 capture radically affordable, whilst efficiently manufacturing high value compounds from carbon. David was formerly a doctor in the British Army having worked in a joint MoD-NHS hospital, and has also spent time working in rural Democratic Republic of Congo in a medical capacity. David has authored 10+ papers in a broad range of topics including COVID-19 vaccines to cyanobacterial genetics and has a passion for supporting initiatives related to Global Health and International Development in Sub-Saharan Africa.